Contec Medical Systems Stock Revenue
| 300869 Stock | 15.12 0.77 4.85% |
Contec Medical Systems fundamentals help investors to digest information that contributes to Contec Medical's financial success or failures. It also enables traders to predict the movement of Contec Stock. The fundamental analysis module provides a way to measure Contec Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Contec Medical stock.
| Last Reported | Projected for Next Year | ||
| Total Revenue | 734 M | 609.6 M |
Contec | Revenue |
Contec Medical Systems Company Revenue Analysis
Contec Medical's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Contec Medical Revenue | 734.05 M |
Most of Contec Medical's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Contec Medical Systems is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Contec Current Deferred Revenue
Current Deferred Revenue |
|
Based on the latest financial disclosure, Contec Medical Systems reported 734.05 M of revenue. This is 90.38% lower than that of the Health Care Equipment & Supplies sector and 71.22% lower than that of the Health Care industry. The revenue for all China stocks is 92.22% higher than that of the company.
Contec Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Contec Medical's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Contec Medical could also be used in its relative valuation, which is a method of valuing Contec Medical by comparing valuation metrics of similar companies.Contec Medical is currently under evaluation in revenue category among its peers.
Contec Fundamentals
| Return On Equity | -0.0097 | ||||
| Return On Asset | -0.0102 | ||||
| Profit Margin | (0.04) % | ||||
| Operating Margin | 0.11 % | ||||
| Current Valuation | 5.67 B | ||||
| Shares Outstanding | 401.8 M | ||||
| Shares Owned By Insiders | 64.21 % | ||||
| Shares Owned By Institutions | 0.37 % | ||||
| Price To Book | 3.14 X | ||||
| Price To Sales | 13.11 X | ||||
| Revenue | 734.05 M | ||||
| Gross Profit | 330 M | ||||
| EBITDA | 136.65 M | ||||
| Net Income | 165.77 M | ||||
| Total Debt | 1.05 B | ||||
| Book Value Per Share | 4.81 X | ||||
| Cash Flow From Operations | 288.68 M | ||||
| Earnings Per Share | (0.05) X | ||||
| Number Of Employees | 1.77 K | ||||
| Beta | -0.083 | ||||
| Market Capitalization | 6.08 B | ||||
| Total Asset | 3.22 B | ||||
| Retained Earnings | 1.09 B | ||||
| Working Capital | 2.02 B | ||||
| Annual Yield | 0.02 % | ||||
| Net Asset | 3.22 B | ||||
| Last Dividend Paid | 0.3 |
About Contec Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Contec Medical Systems's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Contec Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Contec Medical Systems based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Contec Stock
Contec Medical financial ratios help investors to determine whether Contec Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Contec with respect to the benefits of owning Contec Medical security.